West Pharmaceutical-West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance

Conference Call Scheduled for 8 a.m. EDT Today -EXTON, Pa., July 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2025 and a fourth-quarter 2025 dividend.Second-Quarter 2025 Summary (comparisons to prior-year period) Net sales of $766.5 million increased 9.2%; organic net sales growth was 6.8%. Diluted EPS of$ 1.82, compared to $1.51 in the same period last year. Adjusted-diluted EPS of$ 1.84, compared to $1.52 in the same ...